Palla Pharma Share Price and Company Fundamentals



Price
$0.37
Change
0.015 (4.225%)
52 week
0.3475 - 0.879578

Last traded: Today at 6:10 AM

Palla Pharma Limited, a vertically integrated pharmaceutical company, produces and distributes narcotic raw materials, active pharmaceutical ingredients, and finished dosage formulations for pharmaceutical markets in Australia and Norway. It also produces and distributes poppy seeds to culinary markets. The company was formerly known as TPI Enterprises Limited and changed its name to Palla Pharma Limited in June 2019. Palla Pharma Limited was incorporated in 2004 and is headquartered in Melbourne, Australia.

Key Metrics

PE ratio

-

PB ratio

1.29

Dividend yield

Beta

1.40

Market cap

$59.91M

Enterprise value

$62.64M

Company profile

Primary activitiesProduction and distribution of Narcotic Raw Material ("NRM"), Active Pharmaceutical Ingredients ("API") and Finished Dosage Formulations ("FDF") for supply to international pharmaceutical markets.
Industry / SectorFarm Products / Consumer Defensive
Websitehttp://www.pallapharma.com
Mailing addressTower 4 727 Collins Street Melbourne VIC 3008 Australia
Phone / Fax61 3 9301 0800 / 61 3 9301 0899
Share registryLINK MARKET SERVICES LIMITED

Dividends

Palla Pharma does not pay dividends.

Company Executives

As of Jul 2021, following are the company executives and directors listed on Palla Pharma.

NameTitleAgeTotal Pay
Mr. Brendan MiddletonInterim CEO & CFO322.75k
Mr. Jarrod David Ritchie B.Sc., BSc (Hons)Advisor839.35k
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, GAICD, GradDip CSP, FGIACompany Sec.56

Profitability and management effectiveness

Profit margin

-157.91%

Operating margin

-87.49%

Return on assets

-15.33%

Return on equity

-64.64%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Palla Pharma is 59.91M and its enterprise value is 62.64M. The enterprise value to revenue ratio of PAL is 2.85.

The PAL's stocks Beta value is 1.40 making it 40% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Palla Pharma (PAL)

Palla Pharma (ASX:PAL) Frequently Asked Questions

1. What is Palla Pharma's Stock Symbol?

Palla Pharma trades on ASX under the ticker symbol "PAL".

2. What is Palla Pharma's stock price today?

One share of PAL stock can currently be purchased for approximately $0.37.

3. How can I contact Palla Pharma?

Palla Pharma's mailing address is Tower 4 727 Collins Street Melbourne VIC 3008 Australia. The company can be reached via phone at 61 3 9301 0800.

4. What is Palla Pharma's official website?

The official website of Palla Pharma is http://www.pallapharma.com.

5. Which share registry manages Palla Pharma's stock?

Palla Pharma's stock is managed by LINK MARKET SERVICES LIMITED.